EP2292617
1,3-dihydro-imidazo[4,5-c]quinolin-2-ones as lipid kinase and/or pi3 kinase inhibitors
:
EP einkaleyfi: Þýðing ekki lögð inn:
18.5.2006:
11.7.2012:
10175369.7
:
17.5.2026
:
1,3-dihydro-imidazo[4,5-c]quinolin-2-ones as lipid kinase and/or pi3 kinase inhibitors
18.5.2006
11.7.2012
:
Novartis AG:
Lichtstrasse 35, 4056, Basel, CH
:
Garcia-Echeverria, Carlos:
Basel, CH
:
Stauffer, Frédéric:
Reinach, CH
:
Furet, Pascal:
Thann, FR
:
0510390:
20.5.2005:
GB
:
C07D 471/04, A61K 31/4188, A61P 35/00, A61P 29/00, A61P 11/06